NDC directory

Nicardipine Hydrochloride

Fresenius Kabi USA, LLC · INJECTION

65219-296ANDACalcium Channel Antagonists [MoA]
Product NDC
65219-296
Generic name
Nicardipine Hydrochloride
Labeler name
Fresenius Kabi USA, LLC
Brand name
Nicardipine Hydrochloride
Finished
true
Listing expiration date
20271231
Marketing category
ANDA
Dosage form
INJECTION
SPL ID
e0c21d94-9c67-43e5-8bf5-0ad9fb0d0f7a
Product type
HUMAN PRESCRIPTION DRUG
Marketing start date
20261001
Product ID
65219-296_e0c21d94-9c67-43e5-8bf5-0ad9fb0d0f7a
Application number
ANDA219334
Brand name base
Nicardipine Hydrochloride
Active ingredients
  1. Name
    NICARDIPINE HYDROCHLORIDE
    Strength
    .1 mg/mL
Packaging
  1. Package NDC
    65219-296-20
    Description
    10 BAG in 1 CASE (65219-296-20) / 200 mL in 1 BAG (65219-296-01)
    Marketing start date
    20261001
    Sample
    false
Route
INTRAVENOUS
Pharm class
Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.